•  22
    Social and demographic predictors of willingness to participate in an exception from informed consent trial
    with Shannon W. Stephens, Christy Carroll-Ledbetter, Sarah Duckert, Margaret Nelson, Joel Rodgers, Russell L. Griffin, Amy Suen, Steven R. Sloan, Adam McClintock, Sara F. Goldkind, Luke Gelinas, Amanda E. Higley, Bellal Joseph, John B. Holcomb, and Jan O. Jansen
    BMC Medical Ethics 27 (1): 65. 2026.
    Community consultation and public disclosure are key components of exception from informed consent (EFIC) trials, and mandated by the US Department of Health and Human Services (DHHS) and the Food and Drug Administration (FDA). However, it is not known how demographic characteristics of community members impact their willingness to participate in such studies. The purpose of this study was to evaluate the demographics of community members regarding their attitudes towards participation in an EFI…Read more